EP3000870A1 - Fadenpilze mit einem veränderten viskositäts-phänotyp - Google Patents

Fadenpilze mit einem veränderten viskositäts-phänotyp Download PDF

Info

Publication number
EP3000870A1
EP3000870A1 EP15189224.7A EP15189224A EP3000870A1 EP 3000870 A1 EP3000870 A1 EP 3000870A1 EP 15189224 A EP15189224 A EP 15189224A EP 3000870 A1 EP3000870 A1 EP 3000870A1
Authority
EP
European Patent Office
Prior art keywords
gene
seb1
strain
protein
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP15189224.7A
Other languages
English (en)
French (fr)
Other versions
EP3000870B1 (de
Inventor
Elizabeth A. Bodie
Robert James II PRATT
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Danisco US Inc
Original Assignee
Danisco US Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Danisco US Inc filed Critical Danisco US Inc
Publication of EP3000870A1 publication Critical patent/EP3000870A1/de
Application granted granted Critical
Publication of EP3000870B1 publication Critical patent/EP3000870B1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/36—Adaptation or attenuation of cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/07—Nucleotidyltransferases (2.7.7)
    • C12Y207/07013—Mannose-1-phosphate guanylyltransferase (2.7.7.13)

Definitions

  • the present strains and methods relate to genetic mutations in filamentous fungi that give rise to strain variants having altered growth characteristics. Such variants are well-suited for growth in submerged cultures, e.g., for the large-scale production of enzymes and other proteins or metabolites for commercial applications.
  • Filamentous fungi are capable of expressing native and heterologous proteins to high levels, making them well-suited for the large-scale production of enzymes and other proteins for industrial, pharmaceutical, animal health and food and beverage applications.
  • Filamentous fungi are typically grown in mycelial submerged cultures in bioreactors, which are adapted to introduce and distribute oxygen and nutrients into the culture medium (i.e. , broth).
  • the morphological characteristics of the mycelium affect the rheological properties of the broth, thereby affecting bioreactor performance.
  • the higher the viscosity of the broth the less uniform the distribution of oxygen and nutrients and the more energy required to agitate the culture. In some cases, the viscosity of the broth becomes sufficiently high to significantly interfere with the dissolution of oxygen and nutrients, thereby adversely affecting the growth of the fungi. Additionally, the power required to mix and aerate viscous broth can significantly increase the cost of production, and incur higher capital expenditures in terms of motors and power supplies.
  • strains and methods relating to filamentous fungi having genetic alterations that give rise to altered viscosity phenotypes are described.
  • a variant strain of filamentous fungus derived from a parental strain comprising a genetic alteration that causes cells of the variant strain to produce an altered amount of functional Seb1 protein compared to cells of the parental strain, wherein the cells of the variant strain are produced during aerobic fermentation in submerged culture cell broth that (i) requires an altered amount of agitation to maintain a preselected dissolved oxygen content compared to the cells of the parental strain, and/or (ii) maintains an altered dissolved oxygen content at a preselected amount of agitation, compared to the cells of the parental strain.
  • the altered amount of functional Seb1 protein is a reduced amount
  • the variant strain produces during aerobic fermentation in submerged culture a cell broth that (i) requires reduced agitation to maintain a preselected dissolved oxygen content compared to the cells of the parental strain, and/or (ii) maintains an increased dissolved oxygen content at a preselected amount of agitation, compared to the cells of the parental strain.
  • the genetic alteration comprises a disruption of the seb1 gene present in the parental strain.
  • disruption of the seb1 gene is the result of deletion of all or part of the seb1 gene.
  • disruption of the seb1 gene is the result of deletion of a portion of genomic DNA comprising the seb1 gene.
  • disruption of the seb1 gene is the result of mutagenesis of the seb1 gene.
  • disruption of the seb1 gene is performed using site-specific recombination. In some embodiments, disruption of the seb1 gene is performed in combination with introducing a selectable marker at the genetic locus of the seb1 gene.
  • the variant strain does not produce functional Seb1 protein. In some embodiments, the variant strain does not produce Seb1 protein.
  • the variant strain further comprises a gene encoding a protein of interest. In some embodiments, the variant strain further comprises a disruption of the sfb3 gene. In some embodiments, the variant strain further comprises a disruption of the mpg1 gene. In some embodiments, the variant strain further comprises a disruption of the sfb3 and mpg1 genes. In some embodiments, the variant strain further comprises a disruption of at least one gene selected from the group consisting of the sfb3 gene, the mpg1 gene, the gas1 gene, the crz1 gene, and the tps2 gene. In some embodiments, the variant strain produces substantially the same amount of, or more, protein per unit amount of biomass as the parental strain.
  • the filamentous fungus is a Pezizomycotina species. In some embodiments, the filamentous fungus is a Trichoderma spp., Aspergillus spp., Fusarium spp., Scedosporium spp., Penicillium spp., Chrysosporium spp., Cephalosporium spp., Talaromyces spp., Geosmithia spp., and Neurospora spp.
  • the filamentous fungus can include, but is not limited to, Trichoderma reesei (previously classified as Trichoderma longibrachiatun and Hypocrea jecorina ), Aspergillus niger, Aspergillus fumigatus, Aspergillus itaconicus, Aspergillus oryzae, Aspergillus nidulans , Aspergillus terreus, Aspergillus sojae, Aspergillus japonicus, Scedosporium prolificans, Neurospora crassa , Penicillium funiculosum, Penicillium chrysogenum, Talaromyces (Geosmithia) emersonii, Fusarium venenatum, and Chrysosporium lucknowense.
  • the filamentous fungus is Trichoderma reesei.
  • a method for producing a variant strain of filamentous fungus cells comprising: introducing a genetic alteration into a parental strain of filamentous fungal cell, which genetic alteration alters the production of functional Seb1 protein compared to the cells of the parental strain, thereby producing a variant filamentous fungal cell that produces during aerobic fermentation in submerged culture a cell broth that (i) requires an altered amount of agitation to maintain a preselected dissolved oxygen content, compared to the cells of the parental strain, and/or (ii) maintains an altered dissolved oxygen content at a preselected amount of agitation, compared to the cells of the parental strain.
  • the genetic alteration reduces or prevents the production of functional Seb1 protein, thereby producing a variant filamentous fungal cell that produces during aerobic fermentation in submerged culture a cell broth that (i) requires reduced agitation to maintain a preselected dissolved oxygen content, compared to the cells of the parental strain, and/or (ii) maintains an increased dissolved oxygen content at a preselected amount of agitation, compared to the cells of the parental strain.
  • the genetic alteration comprises disrupting the seb1 gene in a parental filamentous fungal cell using genetic manipulation. In some embodiments, the genetic alteration comprises deleting the seb1 gene in a parental filamentous fungal cell using genetic manipulation. In some embodiments, the genetic alteration is performed using site-specific genetic recombination.
  • disruption of the seb1 gene is performed in combination with introducing a selectable marker at the genetic locus of the seb1 gene.
  • the variant strain produces substantially the same amount of, or more, protein per unit amount of biomass as the parental strain.
  • disruption of the seb1 gene is performed in combination with disrupting the sfb3 gene.
  • disruption of the seb1 gene is performed in combination with disrupting the mpg1 gene.
  • disruption of the seb1 gene is performed in combination with disrupting at least one gene selected from the group consisting of the sfb3 gene, the mpg1 gene, the gas1 gene, the crz1 gene, and the tps2 gene.
  • the variant strain produces substantially the same amount of, or more, protein per unit amount of biomass as the parental strain.
  • the filamentous fungus is a Pezizomycotina species. In some embodiments, the filamentous fungus is a Trichoderma spp., Aspergillus spp., Fusarium spp., Scedosporium spp., Penicillium spp., Chrysosporium spp., Cephalosporium spp., Talaromyces spp., Geosmithia spp., and Neurospora spp.
  • the filamentous fungus can include, but is not limited to, Trichoderma reesei (previously classified as Trichoderma longibrachiatum and Hypocrea jecorina ) , Aspergillus niger, Aspergillus fumigatus, Aspergillus itaconicus, Aspergillus oryzae, Aspergillus nidulans, Aspergillus terreus, Aspergillus sojae, Aspergillus japonicus, Scedosporium prolificans, Neurospora crassa, Penicillium funiculosum, Penicillium chrysogenum, Talaromyces (Geosmithia) emersonii, Fusarium venenatum, and Chrysosporium lucknowense.
  • the filamentous fungus is Trichoderma reesei.
  • the parental strain further comprises a gene encoding a protein of interest.
  • the gene encoding the protein of interest is present in the parental strain prior to introducing the genetic alteration that reduces or prevents the production of functional Seb1 protein.
  • the protein of interest within the parental strain is encoded by an endogenous gene or a heterologous gene.
  • a filamentous fungus produced by any of the aforementioned methods and having any of the aforementioned properties is provided.
  • a variant strain of filamentous fungus derived from a parental strain comprising: (a) a genetic alteration that results in (i) a requirement for reduced agitation in submerged culture to maintain a preselected dissolved oxygen content, compared to the cells of the parental strain, and/or (ii) maintenance of an increased dissolved oxygen content in submerged culture at a preselected amount of agitation, compared to the cells of the parental strain, and (b) a gene encoding a protein of interest, wherein the gene encoding the protein of interest is present in the variant strain prior to the genetic alteration in (a).
  • the genetic alteration of the resulting variant strain comprises a disruption of the seb1 gene present in the parental strain.
  • disruption of the seb1 gene is performed in combination with introducing a selectable marker at the genetic locus of the seb1 gene.
  • disruption of the seb1 gene is performed in combination with disrupting the sfb3 gene.
  • disruption of the seb1 gene is performed in combination with disrupting the mpg1 gene.
  • disruption of the seb1 gene is performed in combination with disrupting at least one gene selected from the group consisting of the sfb3 gene, the mpg1 gene, the gas1 gene, the crz1 gene, and the tps2 gene.
  • the present strains and methods relate to variant strains of filamentous fungus cells having genetic modifications that affect their morphology and growth characteristics.
  • the variant cells When the variant cells are grown in submerged culture, they produce a cell broth that has different rheological properties compared to a cell broth comprising cells of the parental strain.
  • Some of these variant strains are well-suited for the large-scale production of enzymes and other commercially important proteins.
  • Trichoderma reesei refers to a filamentous fungus of the phylum Ascomycota, subphylum Pezizomycotina. This organism was previously classified as Trichoderma longibrachiatum, and also as Hypocrea jecorina.
  • variant strain of filamentous fungus cells refer to strains of filamentous fungus cells that are derived ( i.e., obtained from or obtainable from) from a parental (or reference) strain belonging to the Pezizomycotina, e.g., by genetic manipulation.
  • parental and variant strains can be described as having certain characteristics, such as genetic modifications, expression phenotypes, morphology, and the like; however, the skilled person will appreciate that it is technically the cells of the parental or variant strain that have such characteristics, and "the strains" are referred to for convenience.
  • protein of interest refers to a polypeptide that is desired to be expressed in a filamentous fungus.
  • a protein can be an enzyme, a substrate-binding protein, a surface-active protein, a structural protein, or the like, and can be expressed at high levels, and can be for the purpose of commercialization.
  • the protein of interest can be encoded by an endogenous gene or a heterologous gene relative to the variant strain and/or the parental strain.
  • the protein of interest can be expressed intracellularly or as a secreted protein.
  • the phrase "substantially free of an activity," or similar phrases, means that a specified activity is either undetectable in an admixture or present in an amount that would not interfere with the intended purpose of the admixture.
  • polypeptide and protein are used interchangeably to refer to polymers of any length comprising amino acid residues linked by peptide bonds.
  • the conventional one-letter or three-letter codes for amino acid residues are used herein.
  • the polymer can be linear or branched, it can comprise modified amino acids, and it can be interrupted by non-amino acids.
  • the terms also encompass an amino acid polymer that has been modified naturally or by intervention; for example, disulfide bond formation, glycosylation, lipidation, acetylation, phosphorylation, or any other manipulation or modification, such as conjugation with a labeling component.
  • polypeptides containing one or more analogs of an amino acid including, for example, unnatural amino acids, etc.
  • proteins are considered to be "related proteins.” Such proteins can be derived from organisms of different genera and/or species, or even different classes of organisms (e.g., bacteria and fungi). Related proteins also encompass homologs determined by primary sequence analysis, determined by secondary or tertiary structure analysis, or determined by immunological cross-reactivity.
  • the term "derivative polypeptide/protein” refers to a protein which is derived or derivable from a protein by addition of one or more amino acids to either or both the N- and C-terminal end(s), substitution of one or more amino acids at one or a number of different sites in the amino acid sequence, deletion of one or more amino acids at either or both ends of the protein or at one or more sites in the amino acid sequence, and/or insertion of one or more amino acids at one or more sites in the amino acid sequence.
  • the preparation of a protein derivative can be achieved by modifying a DNA sequence which encodes for the native protein, transformation of that DNA sequence into a suitable host, and expression of the modified DNA sequence to form the derivative protein.
  • variant proteins differ from a reference/parental protein (e . g ., a wild-type protein) by substitutions, deletions, and/or insertions at a small number of amino acid residues.
  • the number of differing amino acid residues between the variant and parental protein can be one or more, for example, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 15, 20, 30, 40, 50, or more amino acid residues.
  • Variant proteins can share at least about 70%, at least about 75%, at least about 80%, at least about 85%, at least about 90%, at least about 91%, at least about 92%, at least about 93%, at least about 94%, at least about 95%, at least about 96%, at least about 97%, at least about 98%, or even at least about 99%, or more, amino acid sequence identity with a reference protein,
  • a variant protein can also differ from a reference protein in selected motifs, domains, epitopes, conserved regions, and the like.
  • analogous sequence refers to a sequence within a protein that provides similar function, tertiary structure, and/or conserved residues as the protein of interest (i.e., typically the original protein of interest). For example, in epitope regions that contain an ⁇ -helix or a ⁇ -sheet structure, the replacement amino acids in the analogous sequence preferably maintain the same specific structure.
  • the term also refers to nucleotide sequences, as well as amino acid sequences. In some embodiments, analogous sequences are developed such that the replacement amino acids result in a variant enzyme showing a similar or improved function.
  • the tertiary structure and/or conserved residues of the amino acids in the protein of interest are located at or near the segment or fragment of interest.
  • the replacement amino acids preferably maintain that specific structure.
  • homologous protein refers to a protein that has similar activity and/or structure to a reference protein. It is not intended that homologs necessarily be evolutionary related. Thus, it is intended that the term encompass the same, similar, or corresponding enzyme(s) ( i.e., in terms of structure and function) obtained from different organisms. In some embodiments, it is desirable to identify a homolog that has a quaternary, tertiary and/or primary structure similar to the reference protein. In some embodiments, homologous proteins induce similar immunological response(s) as a reference protein. In some embodiments, homologous proteins are engineered to produce enzymes with desired activity(ies).
  • the degree of homology between sequences can be determined using any suitable method known in the art (see, e.g., Smith and Waterman (1981) Adv. Appl. Math. 2:482 ; Needleman and Wunsch (1970) J. Mol. Biol., 48:443 ; Pearson and Lipman (1988) Proc. Natl. Acad. Sci. USA 85:2444 ; programs such as GAP, BESTFTT, FASTA, and TFASTA in the Wisconsin Genetics Software Package (Genetics Computer Group, Madison, WI); and Devereux et al. (1984) Nucleic Acids Res. 12:387-95 ).
  • PILEUP is a useful program to determine sequence homology levels. PILEUP creates a multiple sequence alignment from a group of related sequences using progressive, pair-wise alignments. It can also plot a tree showing the clustering relationships used to create the alignment. PILEUP uses a simplification of the progressive alignment method of Feng and Doolittle, ( Feng and Doolittle (1987) J. Mol. Evol. 35:351-60 ). The method is similar to that described by Higgins and Sharp ((1989) CABIOS 5:151-53 ), Useful PILEUP parameters including a default gap weight of 3.00, a default gap length weight of 0.10, and weighted end gaps. Another example of a useful algorithm is the BLAST algorithm, described by Altschul et al.
  • BLAST program is the WU-BLAST-2 program (see, e.g., Altschul et al. (1996) Meth. Enzymol. 266:460-80 ). Parameters "W,” "T,” and "X” determine the sensitivity and speed of the alignment.
  • the BLAST program uses as defaults a word-length (W) of 11, the BLOSUM62 scoring matrix (see, e.g., Henikoff and Henikoff (1989) Proc. Natl. Acad. Sci. USA 89:10915 ) alignments (B) of 50, expectation (E) of 10, M'5, N'-4, and a comparison of both strands.
  • the phrases “substantially similar” and “substantially identical,” in the context of at least two nucleic acids or polypeptides, typically means that a polynucleotide or polypeptide comprises a sequence that has at least about 70% identity, at least about 75% identity, at least about 80% identity, at least about 85% identity, at least about 90% identity, at least about 91% identity, at least about 92% identity, at least about 93% identity, at least about 94% identity, at least about 95% identity, at least about 96% identity, at least about 97% identity, at least about 98% identity, or even at least about 99% identity, or more, compared to the reference ( i.e., wild-type) sequence.
  • Sequence identity can be determined using known programs such as BLAST, ALIGN, and CLUSTAL using standard parameters.
  • BLAST Altschul, et al. (1990) J. Mol. Biol. 215:403-410 ; Henikoff et al. (1989) Proc. Natl. Acad. Sci. USA 89:10915 ; Karin et al. (1993) Proc. Natl. Acad. Sci USA 90:5873 ; and Higgins et al. (1988) Gene 73:237-244 ).
  • Software for performing BLAST analyses is publicly available through the National Center for Biotechnology Information. Also, databases can be searched using FASTA ( Pearson et al. (1988) Proc. Natl.
  • polypeptides are substantially identical.
  • first polypeptide is immunologically cross-reactive with the second polypeptide.
  • polypeptides that differ by conservative amino acid substitutions are immunologically cross-reactive.
  • a polypeptide is substantially identical to a second polypeptide, for example, where the two peptides differ only by a conservative substitution.
  • Another indication that two nucleic acid sequences are substantially identical is that the two molecules hybridize to each other under stringent conditions ( e.g., within a range of medium to high stringency).
  • the term "gene” is synonymous with the term “allele” in referring to a nucleic acid that encodes and directs the expression of a protein or RNA. Vegetative forms of filamentous fungi are generally haploid, therefore a single copy of a specified gene ( i.e., a single allele) is sufficient to confer a specified phenotype.
  • wild-type and “native” are used interchangeably and refer to genes proteins or strains found in nature.
  • deletion of a gene refers to its removal from the genome of a host cell.
  • a gene includes control elements (e.g., enhancer elements) that are not located immediately adjacent to the coding sequence of a gene
  • deletion of a gene refers to the deletion of the coding sequence, and optionally adjacent enhancer elements, including but not limited to, for example, promoter and/or terminator sequences.
  • disruption of a gene refers broadly to any genetic or chemical manipulation, i.e., mutation, that substantially prevents a cell from producing a function gene product, e.g., a protein, in a host cell.
  • exemplary methods of disruption include complete or partial deletion of any portion of a gene, including a polypeptide-coding sequence, a promoter, an enhancer, or another regulatory element, or mutagenesis of the same, where mutagenesis encompasses substitutions, insertions, deletions, inversions, and combinations and variations, thereof, any of which mutations substantially prevent the production of a function gene product.
  • a gene can also be disrupted using RNAi, antisense, or any other method that abolishes gene expression.
  • the terms “genetic manipulation” and “genetic alteration” are used interchangeably and refer to the alteration/change of a nucleic acid sequence.
  • the alteration can included but is not limited to a substitution, deletion, insertion or chemical modification of at least one nucleic acid in the nucleic acid sequence.
  • aerobic fermentation refers to growth in the presence of oxygen.
  • cell broth refers collectively to medium and cells in a liquid/submerged culture.
  • cell mass refers to the cell component (including intact and lysed cells) present in a liquid/submerged culture. Cell mass can be expressed in dry or wet weight.
  • rheology refers to a branch of physics dealing with the deformation and flow of matter.
  • viscosity is a measure of the resistance of a fluid to deformation by mechanical stress, such as shear stress or tensile stress.
  • viscosity can also refer to the resistance of a cell broth comprising filamentous fungus cells to mechanical stress, e.g., as provided by a rotor/impeller.
  • viscosity of a cell broth can be difficult to measure directly, indirect measurements of viscosity can be used, such as the dissolved oxygen content of the culture broth at a preselected amount of agitation, the amount of agitation required to maintain a preselected dissolved oxygen content, the amount of power required to agitate a cell broth to maintain a preselected dissolved oxygen content, or even colony morphology on solid medium.
  • an "altered-viscosity" variant strain of filamentous fungus cells refers to a variant strain that produces a cell broth that has either a reduced or increased viscosity (i.e., reduced or increased resistance to shear or tensile stress) compared to an equivalent cell broth produced by a parental strain.
  • equivalent cell broths have comparable cell masses.
  • the difference between a variant, altered viscosity strain and a parental strain, with respect to any direct or indirect measure of viscosity is at least 10%, at least 15%, at least 20%, at least 25%, at least 30%, at least 35%, at least 40%, at least 45%, or even at least 50%, or more.
  • a "reduced-viscosity" variant strain of filamentous fungus cells refers to a variant strain that produces a cell broth that has reduced viscosity (i.e., reduced resistance to shear or tensile stress) compared to an equivalent cell broth produced by a parental strain.
  • the difference between a variant, altered viscosity strain and a parental strain, with respect to any direct or indirect measure of viscosity is at least 10%, at least 15%, at least 20%, at least 25%, at least 30%, at least 35%, at least 40%, at least 45%, or even at least 50%, or more.
  • dissolved oxygen refers to the amount of oxygen (O 2 ) present in a liquid medium as measured in vol/vol units.
  • the dissolved oxygen level can be maintained at a high level, e.g., between 170-100% and 20%, between 100-80% and 20%, between 70% and 20%, between 65% and 20%, between 60% and 20%, between 55% and 20%, between 50% and 20%, between 45% and 20%, between 44% and 20%, between 43% and 20%, between 42% and 20%, between 41% and 20%, between 40% and 20%, between 35% and 20%, between 30% and 20%, and between 25% and 20% throughout the fermentation.
  • the dissolved oxygen can be high at the beginning of the fermentation and to be permitted to fall as the fermentation progresses.
  • the dissolved oxygen level can be controlled by the rate at which the fermentation is agitated, e.g. stirred, and/or by the rate of addition of air or oxygen.
  • the culture can be agitated, e.g., stirred at between 400-700 rpm and the dissolved oxygen level is maintained above 20%, above 25%, above 30%, above 35%, above 40%, above 45%, above 50% and above 55% or more by altering the air or oxygen flow rate and impeller speed.
  • a "primarily genetic determinant" refers to a gene, or genetic manipulation thereof, that is necessary and sufficient to confer a specified phenotype in the absence of other genes, or genetic manipulations, thereof. However, that a particular gene is necessary and sufficient to confer a specified phenotype does not exclude the possibility that additional effects to the phenotype can be achieved by further genetic manipulations.
  • a "functional polypeptide/protein” is a protein that possesses an activity, such as an enzymatic activity, a binding activity, a surface-active property, or the like, and which has not been mutagenized, truncated, or otherwise modified to abolish or reduce that activity.
  • Functional polypeptides can be thermostable or thermolabile, as specified.
  • a functional gene is a gene capable of being used by cellular components to produce an active gene product, typically a protein.
  • Functional genes are the antithesis of disrupted genes, which are modified such that they cannot be used by cellular components to produce an active gene product, or have a reduced ability to be used by cellular components to produce an active gene product.
  • variant cells “maintain or retain a high level of protein expression and/or secretion” compared to a parental strain if the difference in protein expression between the variant strain and a parental strain is less than about 20%, less than about 15%, less than about 10%, less than about 7%, less than about 5%, or even less than about 3%.
  • host cells have been "modified to prevent the production of a specified protein” if they have been genetically or chemically altered to prevent the production of a functional protein/polypeptide that exhibits an activity characteristic of the wild-type protein, particularly an activity that promotes elongation of hyphae or otherwise increases the viscosity of a filamentous fungus in liquid culture.
  • modifications include, but are not limited to, deletion or disruption of the gene encoding the protein (as described, herein), modification of the gene such that the encoded polypeptide lacks the aforementioned activity, modification of the gene to affect post-translational processing or stability, and combinations, thereof.
  • a "protein of interest” is a protein that is desired to be produced in a submerged culture of filamentous fungus cells.
  • proteins of interest are commercially important for industrial, pharmaceutical, animal health, and food and beverage use, making them desirable to produce in large quantities.
  • Proteins of interest are to be distinguished from the myriad other proteins expressed by the filamentous fungus cells, which are generally not of interest as products and are mainly considered background protein contaminants.
  • a variant strain produces "substantially the same amount" of protein per unit amount of biomass as a parental strain if the amount of protein produced by the variant strain is no more than 20% reduced, no more than 15% reduced, no more than 10% reduced, an even no more than 5% reduced compared to the amount of protein produced by the parental strain, wherein the amount of protein is normalized to the total amount of biomass of cells from which protein production is measured, wherein biomass can be expressed in terms of either wet ( e.g., of cell pellet) or dry weight.
  • a variant strain produces "substantially more protein per unit amount of biomass" than a parental strain if the amount of protein produced by the variant strain is at least 5% increased, at least 10% increased, at least 15% increased, or more, compared to the parental strain, wherein the amount of protein is normalized to the total amount of biomass of cells from which protein production is measured, wherein biomass can be expressed in terms of either wet (e.g., of cell pellet) or dry weight.
  • fluorochromes are fluorescent dyes. Preferred fluorochromes bind to cellulose and/or chitin in the cell walls of fungi.
  • a variant strain of filamentous fungus derived from a parental strain comprising a genetic alteration that causes cells of the variant strain to produce an altered amount of functional Seb1 protein compared to cells of the parental strain.
  • the cells of the variant strain subsequently produce, during aerobic fermentation in submerged culture, a cell broth that requires an altered amount of agitation to maintain a preselected dissolved oxygen content, or a cell mass that maintains an altered dissolved oxygen content at a preselected amount of agitation, compared to the cells of the parental strain.
  • the genetic alteration causes cells of the variant strain to produce a reduced amount of functional Seb1 protein compared to cells of the parental strain, and the resulting cell broth requires reduced agitation to maintain a preselected dissolved oxygen content or maintains a higher dissolved oxygen content at a preselected amount of agitation compared to the cells of the parental strain.
  • the cell mass of the variant strain exhibits reduced viscosity compared to a cell mass of the parental strain, which accounts for the observations relating to dissolved oxygen content and agitation, as described in the Examples.
  • the reduction in the amount of functional Seb1 protein can result from disruption of the seb1 gene present in the parental strain. Because disruption of the seb1 gene is a primary genetic determinant for conferring a reduced viscosity phenotype to the variant strain, such variant strains need only comprise a disrupted seb1 gene, while all other genes can remain intact, In some cases, the variant strains can optionally include additional genetic alterations compared to the parental stain from which they are derived. Such additional genetic alterations are not necessary to confer a reduction in viscosity but can further reduce viscosity or confer other advantages for the variant strain.
  • Disruption of the seb1 gene can be performed using any suitable methods that substantially prevent expression of a function seb1 gene product, i.e., the Seb1 protein.
  • Exemplary methods of disruption as are known to one of skill in the art include but are not limited to: Complete or partial deletion of the seb1 gene, including complete or partial deletion of, e.g., the Seb1-coding sequence, the promoter, the terminator, an enhancer, or another regulatory element; and complete or partial deletion of a portion of the chromosome that includes any portion of the seb1 gene.
  • Particular methods of disrupting the seb1 gene include making nucleotide substitutions or insertions in any portion of the seb1 gene, e.g., the Seb1-coding sequence, the promoter, the terminator, an enhancer, or another regulatory element.
  • deletions, insertions, and/or substitutions are made by genetic manipulation using sequence-specific molecular biology techniques, as opposed to by chemical mutagenesis, which is generally not targeted to specific nucleic acid sequences. Nonetheless, chemical mutagenesis can be used to disrupt the seb1 gene.
  • Mutations in the seb1 gene can reduce the efficiency of the seb1 promoter, reduce the efficiency of a seb1 enhancer, interfere with the splicing or editing of the seb1 mRNA, interfere with the translation of the seb1 mRNA, introduce a stop codon into the Seb1-coding sequence to prevent the translation of full-length Seb1 protein, change the coding sequence of the Seb1 protein to produce a less active or inactive protein or reduce Seb1 interaction with other nuclear protein components, change the coding sequence of the Seb1 protein to produce a less stable protein or target the protein for destruction, cause the Seb1 protein to misfold or be incorrectly modified (e.g., by glycosylation), or interfere with cellular trafficking of the Seb1 protein.
  • these and other genetic manipulations act to reduce or prevent the expression of a functional Seb1 protein, or reduce or prevent the normal biological activity of the Seb1 protein, thereby producing a morphology change in the cell that results in a reduced viscosity phenotype.
  • the genetic alteration increases or restores the expression of a functional Seb1 protein, or increases the normal biological activity of the Seb1 protein, thereby producing a morphology change in the cell that results in an increased or restored viscosity phenotype.
  • Exemplary genetic alterations that increase or restore Seb1 function are those that introduce addition copies of the seb1 gene into a cell, increase the efficiency of the seb1 promoter, enhancer, or other control element, increase the translation of the mRNA encoding the Seb1 protein, increase the stability of mRNA encoding the Seb1 protein, introduce changes in the seb1 gene that increase the activity or stability of the Seb1 protein, introduce changes in the seb1 gene that modulate the interaction with other proteins or cell wall components, and the like.
  • Other genetic alterations that increase or restore Seb1 function are those that reverse the effect of genetic alterations that reduce or prevent the expression of a functional Seb1 protein.
  • Filamentous fungus cells for manipulation and use as described are generally from the phylum Ascomycota, subphylum Pezizomycotina, particularly fungi that have a vegetative hyphae state and include a homolog of the seb1 gene.
  • Such organisms include filamentous fungus cells used for the production of commercially important industrial and pharmaceutical proteins, including, but are not limited to Trichoderma spp., Aspergillus spp., Fusarium spp., Scedosporium spp., Penicillium spp., Chrysosporium spp., Cephalosporium spp., Talaromyces spp., Geosmithia spp., and Neurospora spp.
  • Particular organisms include, but are not limited to, Trichoderma reesei (previously classified as Trichoderma longibrachiatum and Hypocrea jecorina ), Aspergillus niger, Aspergillus fumigatus, Aspergillus itaconicus, Aspergillus oryzae, Aspergillus nidulans, Aspergillus terreus, Aspergillus sojae, Aspergillus japonicus, Scedosporium prolificans, Neurospora crassa, Penicillium funiculosum, Penicillium chrysogenum, Talaromyces (Geosmithia) emersonii, Fusarium venenatum , and Chrysosporium lucknowense .
  • Trichoderma reesei previously classified as Trichoderma longibrachiatum and Hypocrea jecorina
  • Aspergillus niger Aspergillus fumigat
  • Seb1 from Trichoderma atroviride is a STRE-element-binding protein, and the seb1 gene is believed to be an orthologue of the yeast msn2 / 4 gene and the Aspergillus nidulans msnA gene. Notably, the seb1 gene cannot complement the msn2 / 4 gene in yeast, so is probably not a functional homologue. Seb1 is involved with but not essential in the osmotic stress response but has not been described previously as being associated with altered morphology, particularly those giving rise to a low viscosity phenotype. The present disclosure provides experimental evidence of the association of Seb1 with altered morphology.
  • the amino acid sequence of the Trichoderma atroviride Seb1 protein is shown, below, as SEQ ID NO: 1:
  • amino acid sequence of the Aspergillus clavatus Scb1 protein is shown, below, as SEQ ID NO: 2:
  • amino acid sequence of the Aspergillus fumigatus Af93 Seb1 protein is shown, below, as SEQ ID NO: 3:
  • Neosartorya fischeri NRRL 181 Seb1 protein The amino acid sequence of the Neosartorya fischeri NRRL 181 Seb1 protein is shown, below, as SEQ ID NO: 4:
  • the predicted amino acid sequence of the Trichoderma reesei Seb1 protein is shown, below, as SEQ ID NO: 5:
  • the amino acid sequence of the Seb1 protein that is altered in production levels has a specified degree of overall amino acid sequence identity to the amino acid sequence of SEQ ID NOs: 1, 2, 3, 4, or 5, e.g., at least about 70%, at least about 75%, at least about 80%, at least about 85%, at least about 90%, at least about 91%, at least about 92%, at least about 93%, at least about 94%, at least about 95%, at least about 96%, at least about 97%, at least about 98%, or even at least about 99% identity, to SEQ ID NOs: 1, 2, 3, 4, or 5.
  • the nucleotide sequences encoding each amino acid sequence can be identified from a BLAST search for each corresponding protein as is know to one skilled in the art.
  • the seb1 gene that is disrupted encodes a Seb1 protein that has a specified degree of overall amino acid sequence identity to the amino acid sequence of SEQ ID NOs: 1, 2, 3, 4, or 5, e.g., at least about 70%, at least about 75%, at least about 80%, at least about 85%, at least about 90%, at least about 91%, at least about 92%, at least about 93%, at least about 94%, at least about 95%, at least about 96%, at least about 97%, at least about 98%, or even at least about 99% identity, to SEQ ID NOs: 1, 2, 3, 4, or 5.
  • amino acid sequence information readily allows the skilled person to identify a Seb1 protein, and the nucleic acid sequence encoding a Seb1 protein, in any filamentous fungi, and to make appropriate disruptions in the seb1 gene to affect the production of the Scb1 protein.
  • the polynucleotide sequences encoding SEQ ID NOs: 1, 2, 3, 4, can be found in the GenBank or JGI databases, as are known to one of skill in the art.
  • a method for altering the morphology of filamentous fungus cells is provided.
  • the variant filamentous fungus cells exhibit altered growth morphology on solid medium and produce cell broth having different viscosities when grown in submerged culture compared to parental cell growth and cell broth viscosities.
  • the method comprises disrupting the seb1 gene in a parental strain using suitable genetic methods, wherein during aerobic fermentation the disrupted seb1 variant strain produces during aerobic fermentation in submerged culture a cell broth that requires reduced agitation to maintain a preselected dissolved oxygen content or maintains an increased dissolved oxygen content at a preselected amount of agitation, compared to the cells of the parental strain.
  • suitable genetic methods can be used to disrupt the seb1 gene in any manner described above and elsewhere as are known to one of skill in the art.
  • disruption of the seb1 gene is performed by genetic manipulation using sequence-specific molecular biology techniques, as opposed to chemical mutagenesis, which is generally not targeted to specific nucleic acid sequences.
  • chemical mutagenesis can be used with satisfactory results.
  • the parental strain into which the reduced viscosity phenotype is introduced creating a reduced viscosity strain already comprises a gene of interest intended to be expressed at high levels.
  • the present methods obviate the need to introduce a gene of interest into a pre-existing reduced viscosity strain for production.
  • the present methods can be used to produce a reduced viscosity variant strain of filamentous fungus cells from a parental strain already comprising a gene of interest.
  • genetic alterations that affect Seb1 production or Mpg1 and Seb1 production are combined with genetic alterations that affect Sfb3 production.
  • the Sfb3 gene also known as Lst1
  • the Sfb3 gene has previously been characterized in budding yeast ( i.e., Saccharomyces cerevisiae ), where it encodes a protein associated with the COPII protein coat surrounding transport vesicles that carry proteins from the endoplasmic reticulum to the Golgi apparatus.
  • Sfb3, as well as Sfb2 are homologs of Sec24, all of which genes are involved with packaging specific cargo proteins into the vesicles.
  • Sec24 is an essential gene in yeast
  • Sfb3 and Sfb2 are not, although the deletion of Sfb3 in yeast is known to affect the transport of a plasma membrane transport protein (Pma1p) and a glucanosyltransferase (Gas1p) that is involved in cell wall synthesis.
  • Pma1p plasma membrane transport protein
  • Gas1p glucanosyltransferase
  • T. reesei has a single gene that is most closely homologous to yeast Sec24 and a single gene that is most closely homologous to yeast Sfb3. No other homolog was identified suggesting that T. reesei does not have a gene equivalent to Sfb2.
  • homologs of the Sfb3 proteins were found in e.g., T. reesei (SEQ ID NO: 6), A . oryzae (SEQ ID NO: 7), A.
  • Trichoderma reesei Sfb3 amino acid sequence (SEQ ID NO: 6):
  • Aspergillus oryzae RIB40 Sfb3 amino acid sequence (GI: 83766074; SEQ ID NO: 7):
  • Penicillium funiculosum Sfb3 amino acid sequence Sfb3 amino acid sequence (SEQ ID NO: 9)
  • Penicillium chrysogenum Sfb3 amino acid sequence SEQ ID NO: 10.
  • Neurospora crassa Sfb3 amino acid sequence (SEQ ID NO: 11)
  • the amino acid sequence of the Sfb3 protein that is altered in production levels has a specified degree of overall amino acid sequence identity to the amino acid sequence of SEQ ID NOs: 6, 7, 8, 9, 10, 11, or 12, e.g., at least about 70%, at least about 75%, at least about 80%, at least about 85%, at least about 90%, at least about 91%, at least about 92%, at least about 93%, at least about 94%, at least about 95%, at least about 96%, at least about 97%, at least about 98%, or even at least about 99% identity, to SEQ ID NOs: 6, 7, 8, 9, 10, 11, or 12.
  • the nucleotide sequences encoding each amino acid sequence can be identified from a BLAST search for each corresponding protein as is know to one skilled in the art.
  • a sfb3 gene is disrupted, wherein the sfb3 gene encodes a Sfb3 protein that has a specified degree of overall amino acid sequence identity to the amino acid sequence of SEQ ID NOs: 6,7, 8, 9, 10, 11, or 12, e.g., at least about 70%, at least about 75%, at least about 80%, at least about 85%, at least about 90%, at least about 91%, at least about 92%, at least about 93%, at least about 94%, at least about 95%, at least about 96%, at least about 97%, at least about 98%, or even at least about 99% identity, to SEQ ID NOs: 6, 7, 8, 9, 10, 11, or 12.
  • Mpg 1(PID 122551) from Trichoderma reesei encodes a GTP:alpha-D-mannose-1-phoshate guanyltransferase.
  • Over-expression of the mpg1 gene increases GDP-mannose levels, which can play a major regulatory role in early stages of protein glycosylation.
  • Mpg1 has heretofore not been associated with altered morphology, particularly not an altered morphology that gives rise to a low viscosity phenotype.
  • the amino acid sequence of the Trichoderma reesei Mpg 1 protein (PID 122551) is shown, below, as SEQ ID NO: 36:
  • the amino acid sequence of the Neurospora crassa Mpg1 protein is shown, below, as SEQ ID NO: 37:
  • amino acid sequence of the Aspergillus oryzae Mannose-1-phosphate guanyltransferase protein is shown, below, as SEQ ID NO: 38:
  • the amino acid sequence of the Mpg1 protein that is altered in production levels has a specified degree of overall amino acid sequence identity to the amino acid sequence of at least one of SEQ ID NOs: 36,37, or 38, e.g., at least about 70%, at least about 75%, at least about 80%, at least about 85%, at least about 90%, at least about 91%, at least about 92%, at least about 93%, at least about 94%, at least about 95%, at least about 96%, at least about 97%, at least about 98%, or even at least about 99% identity, to SEQ ID NOs: 36, 37, or 38.
  • the nucleotide sequences encoding each amino acid sequence can be identified from a BLAST search for each corresponding protein as is know to one skilled in the art.
  • the mpg1 gene that is disrupted encodes a Mpg1 protein that has a specified degree of overall amino acid sequence identity to the amino acid sequence of at least one of SEQ ID NOs: 36, 37, or 38, e.g., at least about 70%, at least about 75%, at least about 80%, at least about 85%, at least about 90%, at least about 91%, at least about 92%, at least about 93%, at least about 94%, at least about 95%, at least about 96%, at least about 97%, at least about 98%, or even at least about 99% identity, to at least one of SEQ ID NOs: 36, 37, or 38.
  • amino acid sequence information readily allows the skilled person to identify an Mpg1 protein, and the nucleic acid sequence encoding an Mpg1 protein, in any filamentous fungi, and to make appropriate disruptions in the mpg1 gene to affect the production of the Mpg1 protein.
  • the polynucleotide sequences encoding SEQ ID NOs: 36, 37, or 38 can be found in the GenBank or JGI databases, as are known to one of skill in the art.
  • reduced viscosity strains of filamentous fungi are known to improve the distribution of oxygen and nutrients in a submerged culture, reduce the amount of energy required to agitate a submerged culture, and increase the cell mass present in the culture, leading to increased protein production.
  • present variant strains of filamentous fungus offer significant advantages over previously-described reduced viscosity strains.
  • the present variant strains can have a fully defined genome, making them well-suited for subsequent genetic manipulation, complementation, mating, and the like.
  • the present strains are not adversely affected in protein production, for example, by the manipulation(s) that resulted in the attendant viscosity alteration.
  • reduced viscosity strains can be produced from essentially any parental strain, including parental strains that already produce a protein intended for high level expression (i.e., a protein of interest), already encode a selectable marker, or already include other features that are desirable in a production host.
  • the present strain and methods eliminate the need to transfer a gene encoding a protein of interest into a preexisting reduced viscosity production strain.
  • the present strains and methods find use in the production of commercially important protein in submerged cultures of filamentous fungi.
  • Commercially important proteins include, for example, cellulases, xylanases, pectinases, lyases, proteases, kinases, amylases, pullulanases, lipases, esterases, perhydrolases, transferases, laccases, catalases, oxidases, reductases, chlorophyllases, hydrophobin, chymosin, carbonic anhydrase, hymidylate synthase, dihydrofolate reductase, tyrosine kinases, multi-drug resistance proteins (e.g., ABC P-gp proteins), CAD (carbamyl-P synthase, aspartate transcarbamylase, dihydroorotase), topoisomerases, ribonucleotide reductase, and antibodies and other enzymes and
  • Example 1 Identification of the seb1 gene as responsible for morphological changes in filamentous fungus
  • Filamentous fungi disruption libraries were prepared by transforming an exemplary filamentous fungus, i.e., Trichoderma reesei, with a nucleic acid containing the pyr4 gene, using Agrobacterium tumefaciens -mediated transformation. In this manner, the pyr4 gene served as both a selectable marker and a gene tag.
  • the particular A . tumefaciens strain used was EHA 105, which is considered to be a hypervirulent (Hood et al., 1993). However, other A . tumefaciens strains, e.g., A136 and EHA 101, produce similar transformation frequencies in T. reesei.
  • A. rhizogenes strains e.g., ATCC 43057, can also be used.
  • the particular disruption library contained about 50,000 transformants.
  • the vector used for disruption was based on the PZP 100 vector, which includes the left and right T-DNA border regions, a pBR322 bom site for mobilization from E. coli to Agrobacterium, ColE1 and pVS1 plasmid origins for replication in E. coli and Agrobacterium, respectively, and a bacterial marker for conferring chloramphenicol resistance (Hajdukiewiez, O. et al., 1994).
  • a representation of the vector is shown in Figure 1B , with a schematic of the T-DNA disruption cassette being shown in Figure 1A .
  • An expression cassette containing the pyr4 gene was prepared by standard molecular biology techniques and ligated into the PZP vector at the Bam HI site.
  • the resulting vector was propagated in E. coli XL gold cells (Invitrogen, Carlsbad, CA, USA).
  • LA agar plates (10 g/L tryptone, 5 g/L yeast extract, 10 g/L NaCl, 10 g/L agar) with 25 ppm chloramphenicol were used to select for E. coli transformants. About 1-10% of the E. coli transformants had the desired vector.
  • E. coli containing the vector were grown in LB medium (10 g/L tryptone, 5 g/L yeast extract, 10 g/L NaCl) plus 25 ppm chloramphenicol.
  • Vector DNA was isolated using standard methods.
  • Competent Agrobacterium cells were made as follows. Briefly, Agrobacterium cells were revived from cryopreservation by growing on LA medium at 28 °C for about three days. Colonies were then selected and grown in LB medium containing 0.1 % glucose in 50 ml volumes in 250 ml dented bottom flasks at 28°C until growth was apparent. Alternatively, colonies were started in a 5 ml culture tube and transferred to a 250 ml flask when growth was apparent. About 10% of the volume of the 250 ml flask was then transferred into a fresh flask with the same medium, which was grown to an OD (600 nm; OD 600 ) of about 0.4-0.8 (about 5-6 hours of growth).
  • the cells were recovered by centrifugation in a cold centrifuge at 10,000 rpm for 10 minutes, and then washed three times in cold 1 M HEPES, pH 7.0. Next, the cells were washed once in cold 1 mM HEPES with 10 % glycerol, and aliquots were frozen at -70°C. Cell viability was determined (typically about 1x10 9 CFU/ml after freezing).
  • the vector DNA was used to transform Agrobacterium cells by electroporation. Competent Agrobacterium cells were thawed on ice and about 40 ⁇ l of the cells were mixed with about 1 ⁇ g of DNA in a 0.2 cm electroporation cell (on ice). The cells were electroporated at 2.5 volts (200 Ohms, at 25 ⁇ F) with a Buchler 3-150 electroporator. SOC medium (Invitrogen) was added to the electroporation cell immediately after electroporation.
  • the Agrabacterium cells can be transformed by electroporation using the ligation mixture, thereby eliminating the need to propagate the vector DNA in E. coli. In the alternative method, about 1 ⁇ l of the ligation mixture is used for transformation.
  • the minimal medium culture was then incubated at 28 °C with shaking until cloudy (overnight to several days). 10 ml of the culture was transferred to 50 ml of induction medium (2.05 g/L K 2 HPO 4 , 1.45 g/L KH 2 PO 4 , 0.15 g/L NaCl, 0.5 g/L MgSO 4 ⁇ 7 ⁇ H 2 O, 0.1 g/L CaCl 2 ⁇ 6 ⁇ H 2 O,0.0025 g/L, FeSO 4 ⁇ 7 ⁇ H 2 O, 0.5 g/L (NH 4 ) 2 SO 4 , 1.8 g/L glucose, 5 g/L glycerol, prepared in 40 mM MES, pH 5.3, with 200 ⁇ L of 1 M acetosyringone added after sterilization) in 250 ml flasks.
  • the staring OD 600 was about 0.1, and the vector-transformed Agrobacterium cells were grown to an OD 600 of about 0.4-0.8.
  • T. reesei T4 ⁇ pyr4 cells a whole-cellulase mutant strain derived from QM6A NRRL 3652, Agricultural Research Service, Beltsville, MD, USA
  • Transformants in the disruption library were screened for alterations in morphology in solid and liquid culture using light microscopy. Following transformation, individual transformants were picked from the nitrocellulose filters using a colony picker and transferred to 96-well microtiter plates containing potato dextrose agar (CP-700, Norgren Systems LLC, Fairlea, WV, USA). Alternatively, spores from transformants were combined, germinated, and single spores were added to microtiter plate wells using a cell sorter. Spores were collected by suspending spores from a Vogel's transformation plate in 20 ml sterile distilled water using a cell spreader.
  • the individual germinates spores were replicate plated into 384 well black sensoplates with glass bottoms (Greiner Bio-one, Germany) containing YEG (5 g yeast extract, 20 g glucose per 1 L water) and incubated at 20°C, for 24 h. The morphology of individual transformants was examined microscopically.
  • Mutant F16 obtained from the above procedure was observed to have altered morphology on plates, and subsequently in liquid culture. On PDA plates Mutant F16, had restricted growth compared to the T4 parent. In liquid medium, F16 appeared to have shorter filaments than the T4 parent.
  • Strains T4 and F16 were grown under identical conditions in submerged (liquid) culture, and their growth phenotypes were compared. Briefly, spores of each strain were added separately to 500-mL of medium in a 3-L flask with both side and bottom baffles. The cultures were grown in a minimal medium for 48 hrs at 34 °C in a shaking incubator.
  • each flask was added separately to 14-L fermentors containing 9.5 L of medium containing 4.7 g/L KH 2 PO 4 , 1.0 g/L MgSO 4 ⁇ 7 ⁇ H 2 O, 4.3 g/L (NH 4 ) 2 SO 4 and 2.5 mL/L of the same trace element solution. These components were heat sterilized together at 121°C for 30 minutes.
  • a solution of 60% glucose and 0.48% CaCl 2 ⁇ 2 ⁇ H 2 O was separately autoclaved, cooled, and added to the fermentor to a final concentration of 75 g/L glucose and 0.6 g/L CaCl 2 ⁇ 2 ⁇ H 2 O.
  • the medium was adjusted to pH 3.5 with 28% NH 3 and the temperature was maintained at 34°C during the growth period. Once glucose was exhausted, the temperature was dropped to 28°C and the cultures were fed glucose-sophorose.
  • a dissolved oxygen (DO) probe was calibrated to 100% when there was no added pressure in the headspace (i . e ., 0 bar gauge, 1 bar absolute). The pressure in the headspace was then set to 0.7 bar (gauge), after which the oxygen probe read 170% before the seed culture was added.
  • the fermentor contained two, four-blade turbines that provided mixing via a variable speed motor that was initially set at 500 rpm.
  • DO content levels dropped, at least partly as a consequence of the increased viscosity of the broth due to the proliferation of filamentous fungus hyphae.
  • the amount of biomass produced in each fermentor was measured, and found to be substantially the same for both strains.
  • the DO content level in each fermentor at a given level of agitation is an indirect measure of the viscosity of the different cell broths, due to the different strain growth phenotypes.
  • Inverse PCR was used to identify the insertion site of the T-DNA pyr4 gene in the F16 mutant by determining the pyr4 flanking regions. Briefly, high molecular-weight genomic DNA from strain F16 was digested to completion with the restriction enzymes Pst I and Nsi I. After heat inactivation of the enzymes, the reaction was diluted five-fold in ligation buffer and T4 DNA ligase was added. Following an overnight ligation reaction, the ligase was heat inactivated and the reaction was precipitated with ammonium acetate and ethanol. The washed DNA pellet was dissolved in TE and used as template for PCR with primers RPG097 and RPG098 (referring to Table 1).
  • This PCR reaction was then diluted and used as template for PCR using nested primers RPG099 and RPG100.
  • the resulting PCR product was cleaned then sequenced with primer RPG116 to determine the nucleotide sequence flanking the site of the T-DNA insertion.
  • BLASTn analysis of this sequence against the JGI Trichoderma reesei database v 2.0 genome sequence identified the flanking sequence as region 1203727 to 1204065 on Scaffold 5, with the site of insertion site of the T-DNA being at position 1203727.
  • primers homologous to the genomic DNA flanking the insertion site were confirmed by PCR using primers homologous to the genomic DNA flanking the insertion site and primers homologous to the T-DNA.
  • primers RPG099 and RPG133 were used to confirm the sequence at the 5' end of the T-DNA (i.e,, near the pyr4 promoter)
  • primers RPG112 and RPG134 were used to confirm the sequence at the 3' end of the T-DNA ( i . e ., near the pyr4 terminator).
  • Primers RPG133 and RPG134 amplified the full T-DNA insertion at the identified site.
  • the site of the pyr4 insertion in mutant F16 was at Scaffold 5 at 1203727 in the T . reesei JGI genomic database v2.
  • the gene found at this site has homology to the seb1 gene found in several other fungi including Aspergillus fumigatus and Trichoderma atroviride.
  • the seb1 gene encodes an AGGGG-binding protein, which appears to be involved in osmotic stress response ( Peterbauer, C. et al. (2002) Molecular Genetics and Genomics 268:223-31 ). Indeed, the F16 strain was found to have a stress response phenotype similar to that described in the literature.
  • the T . reesei Morph 1.1 (i . e ., "Morph") mutant is deleted for four major cellulases genes ( i . e ., cbhI, cbhII, egl1 and eglII ), which makes it useful for expressing other proteins in the absence of cellulase background activity.
  • the ku80 gene was deleted from Morph to increase homologous recombination and aid in the sequence-specific disruption of seb1 .
  • the pyr4 gene was disrupted so that it could be used as a transformation marker.
  • a sebl disruption cassette was prepared by PCR by amplifying the disrupted seb1 gene from DNA obtained from the aforementioned F16 mutant, along with about 500 bp of 5' sebl flanking sequences and about 500 bp of 3' seb1 flanking sequences.
  • Morph1.1 ⁇ ku80 ⁇ pyr4 was transformed using PEG with this deletion cassette, to produce strain Morph1.1 ⁇ ku80 ⁇ pyr4 ⁇ seb1.
  • this strain had an osmotic stress response similar to that of the T. atroviride seb1 -deleted strain described in the literature (Peterbauer, C. et al., 2002).
  • Strains Morph 1.1 ⁇ ku80 and Morph1.1 ⁇ ku80 ⁇ pyr4 ⁇ seb1 were grown under identical conditions in submerged (liquid) culture, and their growth phenotypes were compared. Briefly, spores of each strain were added separately to 500-mL of medium in a 3-L flask with both side and bottom baffles. The culture was grown in a minimal glucose medium for 48 hrs at 34°C in a shaking incubator.
  • each flask was added separately to 14-L fermentors containing 9.5 L of medium containing 4.7 g/L KH 2 PO 4 , 1.0 g/L MgSO 4 ⁇ 7 ⁇ H 2 O, 4.3 g/L (NH 4 ) 2 SO 4 and 2.5 mL/L of the same trace element solution.
  • These components were heat sterilized together at 121°C for 30 minutes.
  • a solution of 60% glucose and 0.48% CaCl 2 ⁇ 2 ⁇ H 2 O was separately autoclaved, cooled, and added to the fermentor to a final concentration of 75 g/L glucose and 0.6 g/L CaCl 2 ⁇ 2 ⁇ H 2 O.
  • the medium was adjusted to pH 3.5 with 28% NH 3 and the temperature was maintained at 34°C for the entire growth period.
  • a dissolved oxygen (DO) probe was calibrated to 100% when there was no added pressure in the headspace (i.e., 0 bar gauge, 1 bar absolute). The pressure in the headspace was then set to 0.7 bar (gauge), after which the oxygen probe read 170% before the seed culture was added.
  • the fermentor contained two, four-blade turbines that provided mixing via a variable speed motor that was initially set at 500 rpm.
  • DO levels dropped, at least partly as a consequence of the increased viscosity of the broth due to the proliferation of filamentous fungus hyphae.
  • the agitation rate was increased to maintain the dissolved oxygen at 40%.
  • DO would be allowed to drop below 40%. If the DO did not fall below 40%, then it was unnecessary to increase the agitation rate during the fermentation run, and the initial agitation rate was higher than necessary.
  • the glucose was completely consumed, the amount of biomass produced in each fermentor was measured, and found to be substantially the same for both strains.
  • the DO level in each fermentor at a given level of agitation, and the amount of agitation required to maintain a given DO level are indirect measures of the viscosity of the different broths, due to the different strain growth phenotypes. Although it would be ideal to vary only one variable (i.e., DO or agitation) and measure the other, it is desirable to prevent the DO from falling below 40% to ensure the production of sufficient biomass in each fermentor, thereby permitting a more meaningful comparison between the growth of the different strains.
  • the amount of agitation can be estimated by the amount of power supplied to the motor driving the fermentor turbine, which provides a metric that correlates with the viscosity of the broth.
  • the extra power required to agitate the suspended culture is proportional to the agitation rate raised to the 3rd power.
  • the Morph strain described above, was previously transformed with a native Trichoderma glucoamylase gene (TrGA) under control of the CBH1 promoter, using amds as a marker.
  • a transformant containing two tandom copies of glucoamylase (TrGA 29-9) was subsequently isolated, and random chemical mutagenesis was used to produce a cell wall mutant (70H2) having altered morphology associated with a reduced viscosity phenotype. This reduced viscosity phenotype was later determined to be the result of a truncated sfb3 gene (data not shown).
  • TrGA #32 has further been useful for overexpressing TrGA.
  • the seb1 disruption cassette plasmid pRATT240 ( Figure 6 ) was prepared using standard molecular biology procedures.
  • This plasmid included a DNA sequence having a 3.3 Kb region homologous to the DNA sequence immediately 5' (relative to seb1 transcription) to the T-DNA insertion site identified in strain T4 F16 and a 3.0 Kb region homologous to the DNA sequence immediately 3' to the T-DNA insertion site.
  • These sequences were designed to target the insertion of the intervening cassette sequences to the insertion site identified in strain T4 F16.
  • These intervening sequences included a pyr 2 selection marker from Trichoderma atroviride intended to minimize homology to the endogenous T.
  • Strain TrGA #32 was transformed with the seb1 disruption cassette using PEG-mediated transformation, and plated on Vogel's minimal medium containing sorbitol to select for candidates based on uridine prototrophy acquired by the pyr2 marker. Individual transformants were isolated by transfer to Vogel's minimal medium. PCR analysis was used to identify transformants in which the seb1 disruption cassette integrated at the seb1 locus by homologous recombination. Homologous integration of the ⁇ seb1 disruption cassette at the seb1 locus was verified by amplifying DNA fragments of the expected sizes using two primer pairs. Primer pair RPG297 and RPG253 amplified a DNA fragment starting outside the 5' end of the disruption cassette region and ending within the 3' region.
  • Primer pair RPG296 and RPG273 amplified a DNA fragment starting within the 5' region of the disruption cassette and ending outside the 3' end of the disruption cassette region. Consistent with disruption, a third primer pair, RPG133 and RPG220, amplified a 1.6 Kb DNA fragment spanning the insertion site using template DNA from the untransformed parental strain but failed to amplify this fragment using template DNA from the seb1 disruption strain.
  • the generated strain with confirmed homologous integration of the seb1 disruption cassette was named TrGA#32 ⁇ seb1.
  • TrGA#32 ⁇ seb1 D. Growth of TrGA#32 ⁇ seb1 in submerged culture
  • TrGA#32 and TrGA#32 ⁇ seb1 were grown under identical conditions in submerged (liquid) culture as described in Example 2, and their growth phenotypes were compared. As shown in Table 3, deletion of the seb1 gene from the TrGA#32 strain resulted in a strain having a further reduction in viscosity (based on the rpm required to maintain a preselected level of dissolved oxygen), indicating that disruption of the seb1 gene and disruption of the sfb3 gene have an additive effect with respect to morphology and viscosity reduction. Protein production was not affected by the seb1 deletion (not shown). Table 3. Growth characteristics of TrGA #32 and TrGA #32 ⁇ seb1 in liquid medium.
  • RPG257 5'-AGATACTAGTGCGAGGCATCCGTGATGGATCTC-3' 22
  • RPG264 5'-GGGTCCCGGGCTCGGGAGCGTAACTCTTGTCC-3' 23
  • RPG296 5'-CACCGGTGAAGCCTTCCGTGAGT-3' 24
  • RPG297 5'-CGCCGTCAGTTGACGACAGTGCT-3' 25
  • RPG253 5'-TTCCTGACAACGAGGACATCTCAAGCTGT-3'
  • RPG273 5'-GGTCAGTAACATAGCAGGACTATAGTAGTGGCTCAC-3'
  • RPG133 5'-GGAGCCAACAGAGACGGTCAGGTT-3' 19
  • RPG220 5'-GCCCAGCGTCGAGTGAGACAAGT-3' 28
  • the Morph strain described above, was previously transformed with a native Trichoderma glucoamylase gene (TrGA) under control of the CBH1 promoter, using amds as a marker.
  • a transformant containing two tandom copies of glucoamylase (TrGA 29-9) was subsequently isolated, and random chemical mutagenesis was used to produce a mutant (77B7).
  • a spontaneous pyr 2 mutant derivative was subsequently isolated by 5-fluoro-orotic acid (FOA) selection.
  • Trichoderma reesei mpg1 (jgi
  • the mpg1 disruption cassette plasmid pRATT249 ( Figure 7 ) was prepared using standard molecular biology procedures. This plasmid included a DNA sequence having a 2.5 Kb region homologous to the DNA sequence spanning part of the 5' untranslated region and contiguous upstream sequences (Left Flank). Also included within the plasmid was a DNA sequence having a 3.3 Kb region homologous to the DNA sequence spanning part of the fourth exon of the mpg1 gene and contiguous downstream sequences (Right Flank). These sequences were designed to target the mpg1 gene and replace the regions of the genome between the Left and Right Flanks with the intervening cassette sequences.
  • pyr 2 selection marker from Trichoderma atroviride intended to minimize homology to the endogenous T. reesei pyr2 in the genome of the strain to be transformed.
  • Immediately upstream of the pyr 2 selection marker was a directly repeated duplication of the 3'end of the marker, which facilitated the subsequent loss of the marker and isolation of useful pyr 2 mutant derivatives of the transformants/disruptants.
  • This full mpg1 disruption cassette was amplified by PCR using primers RPG388 and RPG391. Multiple PCR reactions were pooled and cleaned using standard molecular biology procedures for use in the subsequent steps.
  • Strain Morph TrGA 77B7 was transformed with the mpg1 disruption cassette using PEG-mediated transformation, and plated on Vogel's minimal medium containing sorbitol to select for candidates based on uridine prototrophy acquired by the pyr2 marker. Individual transformants were isolated and propagated by transfer to Vogel's minimal medium. PCR analysis was used to identify transformants in which the mpg1 disruption cassette integrated at the mpg1 locus by homologous recombination. Homologous integration of the ⁇ mpg1 disruption cassette at the mpg1 locus was verified by amplifying DNA fragments of the expected sizes using two primer pairs.
  • Primer pair RPG394 and RPG253 amplified a DNA fragment starting outside the 5' end of the disruption cassette region and ending within the 3' region.
  • Primer pair RPG395 and RPG273 amplified a DNA fragment starting within the 5' region of the disruption cassette and ending outside the 3' end of the disruption cassette region.
  • the generated strain with confirmed homologous integration of the mpg 1 disruption cassette was named TrGA 77B7 ⁇ mpg1
  • TrGA 77B7 ⁇ mpg1 ⁇ seb1 Protein production of TrGA 77B7 ⁇ mpg1 ⁇ seb1 was at least 85% or higher of that of Morph TrGA 77B7 and Morph TrGA 77B7 ⁇ mp1.
  • Table 5 Broth viscosity in TrGA 77B7 ⁇ mpg1 , and TrGA 77B7 ⁇ mpg1 ⁇ seb1 Strain Deletion DO (%) Agitation (rpm) Biomass (g/kg) CER (mmol/L/hr) Morph TrGA 77B7 ⁇ mpg1 mpg1 102 500 42 118 Morph TrGA 77B7 ⁇ mpg1 ⁇ seb1 mpg1 , seb1 110 500 47 112 Table 6.
  • Example 5 Additive viscosity reduction in mutants having disrupted at least one of gas1, crz1 and tps2 genes in conjunction with disrupted mpg1, seb1, and/or sbf3
  • the Gel/Gas/Phr family of fungal ⁇ (1,3)-glucanosyltransferases plays an important role in cell wall biogenesis by processing the main component ⁇ (1,3)-glucan (Popolo et al., 2008).
  • gas1 (PID 22914) encodes a beta-1,3-glucanosyltransferase that is a GPI (and/or glucan)-anchored protein capable of breaking and joining beta-1,3-glucans.
  • GPI and/or glucan
  • a Trichoderma reesei Morph strain was deleted for four major cellulase genes, including cbhI, cbhII , egII, and egIV, which makes it particular suitable for expressing other proteins in the absence of or in reduced cellulase background. See, WO 05/001036 .
  • the Morph strain had been previously transformed with a native Trichoderma glucoamylase gene (TrGA) under control of the CBH1 promoter, using amdS as a marker.
  • a transformant containing two tandom copies of glucoamylase (TrGA 29-9) was subsequently isolated, and random chemical mutagenesis was used to produce a mutant (77B7).
  • a spontaneous pyr2 mutant derivative was subsequently isolated by 5- fluoro-orotic acid (FOA) selection.
  • the Trichoderma reesei gas1 (PID 22914) was deleted from mutant Morph 77B7.
  • Strain Morph TrGA 77B7 ⁇ pyr2 was transformed with a gas1 disruption cassette using PEG-mediated transformation, and plated on Vogel's minimal medium containing sorbitol to select for candidates based on uridine prototrophy acquired by the pyr2 marker.
  • Morph 77B7 ⁇ gas1 has a reduction in broth viscosity compared to the parent Morph 77B7.
  • the Morph 77B7 control strain saw agitation increased to 616 rpm and then saw DO content level drop down to as low as 40%.
  • the strain Morph 77B7 ⁇ gas1 did not require as much energy (i.e., rpm increase in agitation) to achieve the same biomass concentration. Agitation rate never increased above 500 rpm and the % DO never dropped below 115. Protein production was not adversely affected in Morph 77B7 ⁇ gas1 compared to Morph 77B7 (data not shown). Details of the gas1 disruption can be found in U.S. Provisional Application No. 61,480,602, filed April 29, 2011 , incorporated by reference herein in its entirety. Table 8.
  • calcineurin mediated Ca 2+ signaling has been shown to be required for growth, development, and virulence in many organisms. It is necessary for adaption to diverse environmental conditions including high cation levels and alkaline pH.
  • the gene crz 1 encodes a calcineurin-regulated transcription factor.
  • the Crz1p transcription factor is dephosphorylated when the phosphatase calcineurin is activated by Ca 2+ /calmodulin.
  • Trichoderma reesei Morph strain was prepared as described above.
  • the Trichoderma reesei crz1 (PID 36391) was deleted from mutant Morph 77B7.
  • Strain Morph TrGA 77B7 ⁇ pyr2 was transformed with the crz1 disruption cassette using PEG-mediated transformation, and plated on Vogel's minimal medium containing sorbitol to select for candidates based on uridine prototrophy acquired by the pyr2 marker.
  • Morph 77B7 ⁇ crz1 has a reduction in broth viscosity compared to the parent Morph 77B7. At the end of the batch growth phase, when all the glucose has been consumed, both strains had achieved a similar biomass concentration.
  • the Morph 77B7 control strain saw agitation increased to 616 rpm and then saw DO content level drop down to as low as 40%.
  • the strain Morph 77B7 ⁇ crz1 did not require as much energy to achieve the same biomass concentration. Agitation rate never increased above 500 rpm and the % DO never dropped below 100. Details of the crz1 disruption can be found in U.S. Provisional Application No. 61,480,610, filed April 29, 2011 , incorporated by reference herein in its entirety. Table 9.
  • the gene tps2 encodes a trehalose-phosphate phosphatase involved in the synthesis of the disaccharide trehalose.
  • Trehalose is a stress induced sugar that buffers the refolding of denatured proteins in the cytoplasm and ER (Singer, M et al. 1998, Simola, M et al. 2000). This disaccharide is produced in large quantities by diverse organisms in response to a variety of stresses. In yeast, trehalose stabilizes proteins at high temperatures and assists in refolding heat damaged proteins (Simola, M et al. 2000).
  • Trichoderma reesei Morph strain was prepared as described above.
  • the Trichoderma reesei tps2 (PID 48707) was deleted from mutant Morph 77B7.
  • Strain Morph TrGA 77B7 ⁇ pyr2 was transformed with the tps2 disruption cassette using PEG-mediated transformation, and plated on Vogel's minimal medium containing sorbitol to select for candidates based on uridine prototrophy acquired by the pyr 2 marker.
  • Morph 77B7 ⁇ tps2 has a reduction in broth viscosity compared to the parent Morph 77B7.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Cell Biology (AREA)
  • Botany (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
EP15189224.7A 2011-04-22 2012-04-20 Fadenpilze mit einem veränderten viskositäts-phänotyp Active EP3000870B1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161478160P 2011-04-22 2011-04-22
US201161478162P 2011-04-22 2011-04-22
EP12717559.4A EP2663633B1 (de) 2011-04-22 2012-04-20 Fadenpilze mit einem veränderten viskositäts-phänotyp

Related Parent Applications (2)

Application Number Title Priority Date Filing Date
EP12717559.4A Division EP2663633B1 (de) 2011-04-22 2012-04-20 Fadenpilze mit einem veränderten viskositäts-phänotyp
EP12717559.4A Division-Into EP2663633B1 (de) 2011-04-22 2012-04-20 Fadenpilze mit einem veränderten viskositäts-phänotyp

Publications (2)

Publication Number Publication Date
EP3000870A1 true EP3000870A1 (de) 2016-03-30
EP3000870B1 EP3000870B1 (de) 2018-01-24

Family

ID=46018123

Family Applications (3)

Application Number Title Priority Date Filing Date
EP15189224.7A Active EP3000870B1 (de) 2011-04-22 2012-04-20 Fadenpilze mit einem veränderten viskositäts-phänotyp
EP12717559.4A Active EP2663633B1 (de) 2011-04-22 2012-04-20 Fadenpilze mit einem veränderten viskositäts-phänotyp
EP12718831.6A Active EP2699588B1 (de) 2011-04-22 2012-04-20 Fadenpilze mit einem veränderten viskositäts-phänotyp

Family Applications After (2)

Application Number Title Priority Date Filing Date
EP12717559.4A Active EP2663633B1 (de) 2011-04-22 2012-04-20 Fadenpilze mit einem veränderten viskositäts-phänotyp
EP12718831.6A Active EP2699588B1 (de) 2011-04-22 2012-04-20 Fadenpilze mit einem veränderten viskositäts-phänotyp

Country Status (11)

Country Link
US (2) US9725726B2 (de)
EP (3) EP3000870B1 (de)
JP (2) JP6042868B2 (de)
KR (2) KR101952470B1 (de)
CN (2) CN103517916B (de)
AR (2) AR086200A1 (de)
AU (3) AU2012245322A1 (de)
BR (2) BR112013025430A2 (de)
CA (2) CA2833660C (de)
DK (3) DK2663633T3 (de)
WO (2) WO2012145595A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9593341B2 (en) 2011-04-22 2017-03-14 Danisco Us Inc. Filamentous fungi having an altered viscosity phenotype
WO2012145595A1 (en) * 2011-04-22 2012-10-26 Danisco Us Inc. Filamentous fungi having an altered viscosity phenotype
US20180215797A1 (en) * 2015-08-13 2018-08-02 Glykos Finland Oy Regulatory Protein Deficient Trichoderma Cells and Methods of Use Thereof
JP7376505B2 (ja) 2018-04-24 2023-11-08 ダニスコ・ユーエス・インク 粘性が低下した表現型を含む糸状菌株
JP7459509B2 (ja) * 2018-07-30 2024-04-02 東レ株式会社 トリコデルマ属糸状菌の変異株およびタンパク質の製造方法
KR20210038591A (ko) 2018-07-30 2021-04-07 다니스코 유에스 인크. 향상된 단백질 생산성 표현형을 포함하는 돌연변이체 및 유전자 변형된 사상성 진균 균주 및 이의 방법
JP2022553854A (ja) 2019-11-08 2022-12-26 ダニスコ・ユーエス・インク タンパク質生産性が増強された表現型を含む糸状菌株及びその方法
FR3104169B1 (fr) * 2019-12-04 2022-10-21 Ifp Energies Now Souche de champignon ayant une viscosite diminuee
CN113881586B (zh) * 2021-09-27 2023-03-10 四川大学 耐高温、耐高糖、耐高盐酿酒酵母菌株及构建方法和应用
CN118109437B (zh) * 2024-04-29 2024-07-09 北京中医药大学深圳医院(龙岗) 一种来自菌类中药的gdp-甘露糖焦磷酸化酶及其编码基因和应用

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001009352A2 (en) * 1999-07-30 2001-02-08 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek (Tno) Use of aspergillus sojae as host for recombinant protein production
WO2002079399A2 (en) * 2001-03-14 2002-10-10 Genencor International, Inc. Regulatable growth of filamentous fungi
US20040224388A1 (en) * 1999-03-24 2004-11-11 Nigel Dunn-Coleman Hyphal growth in fungi
WO2005001036A2 (en) 2003-05-29 2005-01-06 Genencor International, Inc. Novel trichoderma genes

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI972909A0 (fi) 1997-07-09 1997-07-09 Valtion Teknillinen Oekad produktion av avsoendrade proteiner genom rekombinatjaestceller
CA2405954C (en) * 2000-04-13 2015-06-30 Mark Aaron Emalfarb Novel expression-regulating sequences and expression products in the field of filamentous fungi
AU2002305903A1 (en) * 2001-05-25 2002-12-09 Incyte Genomics Inc. Carbohydrate-associated proteins
US6902921B2 (en) 2001-10-30 2005-06-07 454 Corporation Sulfurylase-luciferase fusion proteins and thermostable sulfurylase
CA2699413C (en) 2007-09-11 2013-09-10 Mark Banks Insulated pallet shipper and methods of making and using the same
KR101768225B1 (ko) * 2008-03-07 2017-08-14 다니스코 유에스 인크. 트리코데르마에서의 카탈라아제 발현
JP5707494B2 (ja) 2010-08-25 2015-04-30 ダニスコ・ユーエス・インク 粘性の表現型を変化させた糸状菌
WO2012145595A1 (en) * 2011-04-22 2012-10-26 Danisco Us Inc. Filamentous fungi having an altered viscosity phenotype
US9593341B2 (en) * 2011-04-22 2017-03-14 Danisco Us Inc. Filamentous fungi having an altered viscosity phenotype

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040224388A1 (en) * 1999-03-24 2004-11-11 Nigel Dunn-Coleman Hyphal growth in fungi
WO2001009352A2 (en) * 1999-07-30 2001-02-08 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek (Tno) Use of aspergillus sojae as host for recombinant protein production
WO2002079399A2 (en) * 2001-03-14 2002-10-10 Genencor International, Inc. Regulatable growth of filamentous fungi
WO2005001036A2 (en) 2003-05-29 2005-01-06 Genencor International, Inc. Novel trichoderma genes

Non-Patent Citations (54)

* Cited by examiner, † Cited by third party
Title
AGORCE ET AL., J. BIOL.CHEM., vol. 278, 2003, pages 20345 - 20357
ALTSCHUL ET AL., J. MOL. BIOL., vol. 215, 1990, pages 403 - 410
ALTSCHUL ET AL., METH. ENZYMOL., vol. 266, 1996, pages 460 - 80
ALTSCHUL, J. MOL. BIOL., vol. 215, 1990, pages 403 - 10
BORGIA P T ET AL: "THE ORLA GENE FROM ASPERGILLUS NIDULANS ENCODES A TREHALOSE-6- PHOSPHATE PHOSPHATASE NECESSARY FOR NORMAL GROWTH AND CHITIN SYNTHESIS AT ELEVATED TEMPERATURES", MOLECULAR MICROBIOLOGY, vol. 20, no. 6, 1 June 1996 (1996-06-01), WILEY-BLACKWELL PUBLISHING LTD, GB, pages 1287 - 1296, XP002060302, ISSN: 0950-382X, DOI: 10.1111/J.1365-2958.1996.TB02647.X *
BURLINGAME RP, VERDOES JC: "Maximizing Protein Expression in Filamentous Fungi", 1 May 2006 (2006-05-01), XP002680849, Retrieved from the Internet <URL:http://license.icopyright.net/user/viewFreeUse.act?fuid=MTY0ODk0ODU%3D> [retrieved on 20120730] *
CARACUEL, Z. ET AL., MOLECULAR PLANT-MICROBE INTERACTIONS, vol. 18, 2005, pages 1140 - 47
DAI ZIYU ET AL: "Identification of genes associated with morphology in Aspergillus niger by using suppression subtractive hybridization", APPLIED AND ENVIRONMENTAL MICROBIOLOGY, vol. 70, no. 4, 1 April 2004 (2004-04-01), AMERICAN SOCIETY FOR MICROBIOLOGY, US, pages 2474 - 2485, XP002428202, ISSN: 0099-2240, DOI: 10.1128/AEM.70.4.2474-2485.2004 *
DEVEREUX ET AL., NUCLEIC ACIDS RES., vol. 12, 1984, pages 387 - 95
FENG; DOOLITTLE, J. MOL. EVOL., vol. 35, 1987, pages 351 - 60
GARCIA ET AL., J. BIO. CHEM., vol. 279, 2004, pages 15183 - 15195
HAJDUKICWICZ, P. ET AL., PLANT MOLECULAR BIOLOGY, vol. 25, 1994, pages 989 - 94
HENIKOFF ET AL., PROC: NATL. ACAD. CI. USA, vol. 89, 1989, pages 10915
HENIKOFF; HENIKOFF, PROC. NATL. ACAD. SEL. USA, vol. 89, 1989, pages 10915
HIGGINS ET AL., GENE, vol. 73, 1988, pages 237 - 244
HIGGINS; SHARP, CABIOS, vol. 5, 1989, pages 151 - 53
HOOD, E.E. ET AL., TRANGENIC RESEARCH, vol. 2, 1993, pages 208 - 18
HUGHES, H; STEPHENS, D.J., CELL BIOL, vol. 129, 2008, pages 129 - 51
I. V. GRIGORIEV; H. NORDBERG; I. SHABALOV; A. AERTS; CANTOR; D. GOODSTEIN; A. KUO; S. MINOVITSKY; R. NIKITIN; R. A. OHM, NUCLEIC ACIDS RES, 2011
KARABABA ET AL., MOL. MICROBIOL., vol. 59, 2006, pages 1429 - 1451
KARHINEN, L. ET AL., TRAFFIC, vol. 6, 2005, pages 562 - 74
KARIN ET AL., PROC. NATL. ACAD. SC USA, vol. 90, 1993, pages 5873
KARLIN ET AL., PROC. NATL. ACAD, SCI. USA, vol. 90, 1993, pages 5873 - 87
KOTHE, G.; FREE, ., FUNGAL GENET. BIOL, vol. 23, 1998, pages 248 - 258
KRUSZEWSKA ET AL., CUR. GENET., vol. 33, 1998, pages 445 - 50
MOUYNA, I., MOLECULAR MICROBIOLOGY, vol. 56, 2005, pages 1675 - 88
NEEDLEMAN; WUNSCH, J. MOL. BIOL., vol. 48, 1970, pages 443
PAPAGIANNI M: "Fungal morphology and metabolite production in submerged mycelial processes", BIOTECHNOLOGY ADVANCES, vol. 22, no. 3, 1 January 2004 (2004-01-01), ELSEVIER PUBLISHING, BARKING, GB, pages 189 - 259, XP004479966, ISSN: 0734-9750, DOI: 10.1016/J.BIOTECHADV.2003.09.005 *
PARDINI ET AL., J. BIOL. CHEM., vol. 281, 2006, pages 40399 - 40411
PASSOLUNGHI, S ET AL., MICROBIAL CELL FACTORIES, vol. 9, 2010, pages 7 - 17
PEARSON ET AL., PROC. NATL. ACAD SCI. US, vol. 85, 1988, pages 2444 - 48
PEARSON; LIPMAN, ROC. NATL. ACAD. SCI. USA, vol. 85, 1988, pages 2444
PETERBAUER C K ET AL: "The Trichoderma atroviride seb1 (stress response element binding) gene encodes an AGGGG-binding protein which is involved in the response to high osmolarity stress.", MGG MOLECULAR GENETICS AND GENOMICS, vol. 268, no. 2, October 2002 (2002-10-01), pages 223 - 231, XP002680848, ISSN: 1617-4615 *
PETERBAUER ET AL., MOLECULAR GENETICS AND GENOMICS, vol. 268, 2002, pages 223 - 31
PETERBAUER, C ET AL., MOLECULAR GENETICS AND GENOMICS, vol. 268, 2002, pages 223 - 31
PETERBAUER, C. ET AL., MOLECULAR GENETICS ANDGENOMICS, vol. 268, 2002, pages 223 - 31
PMKISCH, H. ET AL., GEN. GENET., vol. 256, 1997, pages 104 - 114
PONG, R. ET AL., J. BIOL. CHEM., vol. 275, 2000, pages 11521 - 28
POPOLO,L ET AL., J. BIOL. CHEM., vol. 283, 2008, pages 18553 - 18565
R. PENG: "Evidence for Overlapping and Distinct Functions in Protein Transport of Coat Protein Sec24p Family Members", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 275, no. 15, 6 April 2000 (2000-04-06), pages 11521 - 11528, XP055015580, ISSN: 0021-9258, DOI: 10.1074/jbc.275.15.11521 *
ROBERG, K.J. ET AL., J. CELL. BIOL., vol. 145, 1999, pages 659 - 72
SCHIRAWSKI JAN ET AL: "Endoplasmic reticulum glucosidase II is required for pathogenicity of Ustilago maydis.", THE PLANT CELL, vol. 17, no. 12, December 2005 (2005-12-01), pages 3532 - 3543, XP002680850, ISSN: 1040-4651 *
SCHIRAWSKI, J ET AL., PLANT CELL, vol. 17, 2005, pages 3532 - 3543
SCHUMACHER JULIA ET AL: "Calcineurin-responsive zinc finger transcription factor CRZ1 of Botrytis cinerea is required for growth, development, and full virulence on bean plants", EUKARYOTIC CELL, vol. 7, no. 4, April 2008 (2008-04-01), pages 584 - 601, XP002680851, ISSN: 1535-9778 *
SHIMONI, Y. ET AL., J. CELL. BIOL., vol. 151, 2000, pages 973 - 84
SIMOLA, M, MOL. MICROBIOL., vol. 37, 2000, pages 42 - 53
SINGER, M.; LINDQUIST S., MOL. CELL, vol. 5, 1998, pages 639 - 48
SMITH; WATERMAN, ADV. PPL. MATH., vol. 2, 1981, pages 482
TALBOT N ET AL: "Identification and characterization of MPG1, a gene", THE PLANT CELL, vol. 5, no. 11, 1 November 1993 (1993-11-01), AMERICAN SOCIETY OF PLANT BIOLOGISTS, US, pages 1575 - 1590, XP002103524, ISSN: 1040-4651, DOI: 10.1105/TPC.5.11.1575 *
TURCHINI, A ET AL., J. BACTERIOL., vol. 182, 2000, pages 1167 - 71
UNRO, C. ET AL., MOL. MICROBIOL, vol. 63, 2009, pages 1399 - 1413
VOGEL, MICROBIOL. GENET. BULL., vol. 13, 1956, pages 42 - 43
YOSHIMOTO ET AL., J. BIOL. CHEM., vol. 227, 2002, pages 31079 - 31088
ZAKRZEWSKA ET AL., APPLIED AND ENVIROMNETAL MICROBIOLOGY, vol. 59, 2003, pages 4383 - 89

Also Published As

Publication number Publication date
KR101993939B1 (ko) 2019-06-27
JP6042868B2 (ja) 2016-12-14
CA2833660C (en) 2020-08-04
DK2699588T3 (en) 2017-03-13
EP2699588B1 (de) 2016-11-30
US20140094587A1 (en) 2014-04-03
EP2663633A1 (de) 2013-11-20
BR112013025203A2 (pt) 2016-11-29
DK3000870T3 (en) 2018-04-30
CA2833541A1 (en) 2012-10-26
EP3000870B1 (de) 2018-01-24
AU2012245402A1 (en) 2013-08-22
EP2663633B1 (de) 2016-02-24
US20140099721A1 (en) 2014-04-10
KR101952470B1 (ko) 2019-02-26
JP2014513529A (ja) 2014-06-05
JP6042866B2 (ja) 2016-12-14
AR086200A1 (es) 2013-11-27
CN103517916B (zh) 2017-05-10
CA2833541C (en) 2021-04-27
US9725727B2 (en) 2017-08-08
WO2012145595A1 (en) 2012-10-26
KR20140033053A (ko) 2014-03-17
CN103502431B (zh) 2016-07-06
WO2012145584A1 (en) 2012-10-26
CN103502431A (zh) 2014-01-08
AU2012245322A1 (en) 2013-08-22
AU2012245402B2 (en) 2017-09-28
BR112013025430A2 (pt) 2016-11-29
US9725726B2 (en) 2017-08-08
EP2699588A1 (de) 2014-02-26
CA2833660A1 (en) 2012-10-26
AU2017202753A1 (en) 2017-05-18
JP2014513531A (ja) 2014-06-05
DK2663633T3 (en) 2016-05-23
CN103517916A (zh) 2014-01-15
AR086201A1 (es) 2013-11-27
KR20140033048A (ko) 2014-03-17

Similar Documents

Publication Publication Date Title
US9593341B2 (en) Filamentous fungi having an altered viscosity phenotype
EP2663633B1 (de) Fadenpilze mit einem veränderten viskositäts-phänotyp

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20151028

AC Divisional application: reference to earlier application

Ref document number: 2663633

Country of ref document: EP

Kind code of ref document: P

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

17Q First examination report despatched

Effective date: 20170410

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

INTG Intention to grant announced

Effective date: 20170807

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AC Divisional application: reference to earlier application

Ref document number: 2663633

Country of ref document: EP

Kind code of ref document: P

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

Ref country code: CH

Ref legal event code: NV

Representative=s name: SERVOPATENT GMBH, CH

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 965794

Country of ref document: AT

Kind code of ref document: T

Effective date: 20180215

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602012042512

Country of ref document: DE

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 7

REG Reference to a national code

Ref country code: NL

Ref legal event code: FP

REG Reference to a national code

Ref country code: DK

Ref legal event code: T3

Effective date: 20180426

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG4D

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 965794

Country of ref document: AT

Kind code of ref document: T

Effective date: 20180124

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180124

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180424

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180124

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180124

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180124

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180124

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180124

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180425

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180124

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180124

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180524

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180424

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180124

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602012042512

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180124

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180124

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180124

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180124

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180124

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180124

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180124

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180124

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20180424

26N No opposition filed

Effective date: 20181025

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180420

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180124

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180424

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180420

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180420

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180124

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180124

REG Reference to a national code

Ref country code: CH

Ref legal event code: PCAR

Free format text: NEW ADDRESS: WANNERSTRASSE 9/1, 8045 ZUERICH (CH)

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20120420

Ref country code: MK

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180124

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: CH

Payment date: 20220314

Year of fee payment: 11

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20220308

Year of fee payment: 11

P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20230530

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DK

Payment date: 20230414

Year of fee payment: 12

Ref country code: DE

Payment date: 20230307

Year of fee payment: 12

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FI

Payment date: 20230411

Year of fee payment: 12

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20230430

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20230430

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20230430

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NL

Payment date: 20240315

Year of fee payment: 13

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: BE

Payment date: 20240319

Year of fee payment: 13